PRTC vs. ONT, GNS, ERGO, SLN, OXB, HZD, FARN, VRP, ARIX, and CIR
Should you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Oxford Nanopore Technologies (ONT), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), and Circassia Group (CIR). These companies are all part of the "biotechnology" industry.
PureTech Health vs.
Oxford Nanopore Technologies (LON:ONT) and PureTech Health (LON:PRTC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, community ranking, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.
38.4% of Oxford Nanopore Technologies shares are held by institutional investors. Comparatively, 79.9% of PureTech Health shares are held by institutional investors. 32.6% of Oxford Nanopore Technologies shares are held by company insiders. Comparatively, 15.9% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Oxford Nanopore Technologies has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.
PureTech Health received 496 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 86.60% of users gave PureTech Health an outperform vote.
PureTech Health has lower revenue, but higher earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than PureTech Health, indicating that it is currently the more affordable of the two stocks.
Oxford Nanopore Technologies presently has a consensus target price of GBX 233.33, suggesting a potential upside of 98.37%. PureTech Health has a consensus target price of GBX 455, suggesting a potential upside of 261.69%. Given PureTech Health's higher probable upside, analysts plainly believe PureTech Health is more favorable than Oxford Nanopore Technologies.
Oxford Nanopore Technologies has a net margin of -94.82% compared to PureTech Health's net margin of -17,620.94%. PureTech Health's return on equity of -21.15% beat Oxford Nanopore Technologies' return on equity.
In the previous week, PureTech Health had 1 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 1 mentions for PureTech Health and 0 mentions for Oxford Nanopore Technologies. PureTech Health's average media sentiment score of 1.11 beat Oxford Nanopore Technologies' score of 0.00 indicating that PureTech Health is being referred to more favorably in the news media.
Summary
PureTech Health beats Oxford Nanopore Technologies on 11 of the 17 factors compared between the two stocks.
Get PureTech Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PureTech Health Competitors List
Related Companies and Tools
This page (LON:PRTC) was last updated on 4/29/2025 by MarketBeat.com Staff
Buy PRTC Stock Free PRTC Stock Alerts